Article
Possible Role of Amyloidogenic Evolvability in Dementia with Lewy Bodies: Insights from Transgenic Mice Expressing P123H β-Synuclein.
International journal of molecular sciences - 19 Apr 2020
Fujita Masayo, Ho Gilbert, Takamatsu Yoshiki, Wada Ryoko, Ikeda Kazutaka, Hashimoto Makoto
Abstract excerpt
Dementia with Lewy bodies (DLB) is the second most prevalent neurodegenerative dementia after Alzheimer's disease, and is pathologically characterized by formation of intracellular inclusions called Lewy bodies, the major constituent of which is aggregated α-synuclein (αS). Currently, neither a mechanistic etiology nor an effective disease-modifying therapy for DLB has been established. Although two missense...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
